{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:04:05Z","timestamp":1789513445074,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009473","name":"University of Malaga","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clnu.2026.106747","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:20:06Z","timestamp":1785453606000},"page":"106747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Physical, mental and biochemical effects of probiotics in multiple sclerosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"64","author":[{"given":"Tamar","family":"Blanca-Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Agredano-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda","family":"L\u00f3pez Gigosos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Francisco","family":"Jim\u00e9nez Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8248-3904","authenticated-orcid":false,"given":"Carmen Mar\u00eda","family":"Gonz\u00e1lez-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Guti\u00e9rrez-Bedmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2026.106747_bib1","series-title":"Atlas of MS web site","year":"2022"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41598-022-04836-5","article-title":"Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France","volume":"12","author":"Gbaguidi","year":"2022","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.clnu.2026.106747_bib3","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005612","article-title":"Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women","volume":"90","author":"Koch-Henriksen","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.clnu.2026.106747_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.100977","article-title":"Multiple sclerosis: emerging epidemiological trends and redefining the clinical course","volume":"44","author":"Portaccio","year":"2024","journal-title":"The Lancet Regional Health - Europe"},{"issue":"10","key":"10.1016\/j.clnu.2026.106747_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-0043-1771462","article-title":"Gastrointestinal dysfunction in multiple sclerosis and related conditions","volume":"43","author":"Sakakibara","year":"2023","journal-title":"Semin Neurol"},{"key":"10.1016\/j.clnu.2026.106747_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105115","article-title":"Multiple sclerosis vision questionnaire (MSVQ-7): reliability, validity, precision and discrimination","volume":"80","author":"Young","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"10.1016\/j.clnu.2026.106747_bib8","doi-asserted-by":"crossref","first-page":"fcae355","DOI":"10.1093\/braincomms\/fcae355","article-title":"Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study","volume":"6","author":"Ziccardi","year":"2024","journal-title":"Brain Communications"},{"issue":"2","key":"10.1016\/j.clnu.2026.106747_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/1352458517717808","article-title":"Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations","volume":"24","author":"De Stefano","year":"2018","journal-title":"Multiple Sclerosis Journal"},{"issue":"6","key":"10.1016\/j.clnu.2026.106747_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/13524585241245306","article-title":"Radiologically isolated syndrome in the spectrum of multiple sclerosis","volume":"30","author":"Okuda","year":"2024","journal-title":"Multiple Sclerosis Journal"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00415-023-12021-5","article-title":"Identification and management of subclinical disease activity in early multiple sclerosis: a review","volume":"271","author":"Ontaneda","year":"2024","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener Dis Manag"},{"issue":"9","key":"10.1016\/j.clnu.2026.106747_bib14","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.clnu.2026.106747_bib15","article-title":"Association between comorbidities and health-related quality of life in patients with multiple sclerosis","author":"Mirmosayyeb","year":"2025","journal-title":"Neurologia"},{"key":"10.1016\/j.clnu.2026.106747_bib16","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2019","journal-title":"Front Immunol"},{"issue":"7878","key":"10.1016\/j.clnu.2026.106747_bib79","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2026.106747_bib17","article-title":"Immunomodulatory potential of human mesenchymal stem cells and their exosomes on multiple sclerosis","volume":"1","author":"Baharlooi","year":"2021","journal-title":"Adv Pharmaceut Bull"},{"key":"10.1016\/j.clnu.2026.106747_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1305933","article-title":"Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression","volume":"14","author":"Fornari Laurindo","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/1744666X.2024.2401614","article-title":"Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis","volume":"21","author":"Nasrabadi","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clnu.2026.106747_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577700","article-title":"The second brain: the connection between gut microbiota composition and multiple sclerosis","volume":"360","author":"Farshbafnadi","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.clnu.2026.106747_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718220","article-title":"The gut-brain axis in multiple sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease?","volume":"12","author":"Parodi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2026.106747_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590783","article-title":"Alterations of the fecal microbiota in Chinese patients with multiple sclerosis","volume":"11","author":"Ling","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-022-01148-1","article-title":"The gut microbiota in multiple sclerosis varies with disease activity","volume":"15","author":"Thirion","year":"2023","journal-title":"Genome Med"},{"key":"10.1016\/j.clnu.2026.106747_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2020.00947","article-title":"Interleukin-17 in chronic inflammatory neurological diseases","volume":"11","author":"Milovanovic","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2026.106747_bib81","doi-asserted-by":"crossref","first-page":"661493","DOI":"10.3389\/fimmu.2021.661493","article-title":"Serum short-chain fatty acids and associations with inflammation in newly diagnosed patients with multiple sclerosis and healthy controls","volume":"12","author":"Olsson","year":"2021","journal-title":"Front Immunol"},{"issue":"18","key":"10.1016\/j.clnu.2026.106747_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810729","article-title":"Gut dysbiosis and fecal microbiota transplantation in autoimmune diseases","volume":"23","author":"Belvoncikova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.clnu.2026.106747_bib25","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/cells12141872","article-title":"The gut\u2013brain axis as a therapeutic target in multiple sclerosis","volume":"12","author":"Buga","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clnu.2026.106747_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107456","article-title":"New therapeutic avenues in multiple sclerosis: is there a place for gut microbiota-based treatments?","volume":"209","author":"Campagnoli","year":"2024","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.clnu.2026.106747_bib27","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cmet.2018.05.006","article-title":"Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota","volume":"27","author":"Cignarella","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnu.2026.106747_bib28","series-title":"Joint FAO\/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria","year":"2001"},{"issue":"8","key":"10.1016\/j.clnu.2026.106747_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2026.106747_bib30","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.biopha.2017.08.117","article-title":"Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance","volume":"95","author":"Salehipour","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.clnu.2026.106747_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009009","article-title":"A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells","volume":"5","author":"Lavasani","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2026.106747_bib33","article-title":"Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: a single-center, randomized clinical trial","volume":"53","author":"Moravejolahkami","year":"2023","journal-title":"Compl Ther Clin Pract"},{"key":"10.1016\/j.clnu.2026.106747_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105762","article-title":"A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: trial feasibility, supplement tolerability and symptom abatement","volume":"89","author":"Straus Farber","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"10","key":"10.1016\/j.clnu.2026.106747_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/14737175.2023.2250919","article-title":"The role of fecal microbiota transplantation (FMT) in treating patients with multiple sclerosis","volume":"23","author":"Zhanel","year":"2023","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12974-019-1611-4","article-title":"Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review","volume":"16","author":"Morshedi","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"24","key":"10.1016\/j.clnu.2026.106747_bib37","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.3390\/jcm12247610","article-title":"Modulating the gut microbiome in multiple sclerosis management: a systematic review of current interventions","volume":"12","author":"Tsogka","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319755","article-title":"The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: a worldwide systematic review and meta-analysis","volume":"20","author":"Zangeneh","year":"2025","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clnu.2026.106747_bib39","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1039\/D0FO03203D","article-title":"Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials","volume":"12","author":"Jiang","year":"2021","journal-title":"Food Funct"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/lam.13543","article-title":"The efficacy of probiotics in experimental autoimmune encephalomyelitis (an animal model for MS): a systematic review and meta-analysis","volume":"73","author":"Valizadeh","year":"2021","journal-title":"Lett Appl Microbiol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","article-title":"Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"6","author":"Chen","year":"2025","journal-title":"Molecular Biomedicine"},{"issue":"9","key":"10.1016\/j.clnu.2026.106747_bib42","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s11010-023-04853-6","article-title":"The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances","volume":"479","author":"Li","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.clnu.2026.106747_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122952","article-title":"The gut microbiota\u2013oligodendrocyte axis: a promising pathway for modulating oligodendrocyte homeostasis and demyelination-associated disorders","volume":"354","author":"Tang","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.clnu.2026.106747_bib44","series-title":"Cochrane Methods 2016","author":"Chandler","year":"2016"},{"key":"10.1016\/j.clnu.2026.106747_bib45","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"l4898","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.clnu.2026.106747_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/1028415X.2020.1758887","article-title":"Effects of long-term administration of multi-strain probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Rahimlou","year":"2020","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.clnu.2026.106747_bib48","article-title":"Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Rahimlou","year":"2022","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46047-6","article-title":"The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial","volume":"13","author":"Asghari","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.clnu.2026.106747_bib50","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","article-title":"Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Kouchaki","year":"2017","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2026.106747_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.34172\/PS.025.41013","article-title":"The effects of probiotic supplementation on level of disability, depressive symptoms, and cognitive outcomes in relapsing-remitting multiple sclerosis patients: a randomized double-blind placebo-controlled trial","volume":"31","author":"Naseri","year":"2025","journal-title":"Pharm Sci"},{"key":"10.1016\/j.clnu.2026.106747_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jff.2018.10.023","article-title":"How probiotic bacteria influence the motor and mental behaviors as well as immunological and oxidative biomarkers in multiple sclerosis? A double blind clinical trial","volume":"52","author":"Salami","year":"2019","journal-title":"J Funct Foods"},{"issue":"8","key":"10.1016\/j.clnu.2026.106747_bib53","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/07315724.2017.1347074","article-title":"Retracted article: the effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Tamtaji","year":"2017","journal-title":"J Am Coll Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1352458517737390","article-title":"Investigation of probiotics in multiple sclerosis","volume":"24","author":"Tankou","year":"2018","journal-title":"Multiple Sclerosis Journal"},{"issue":"6","key":"10.1016\/j.clnu.2026.106747_bib78","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ana.25244","article-title":"A probiotic modulates the microbiome and immunity in multiple sclerosis","volume":"83","author":"Tankou","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clnu.2026.106747_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clnu.2025.08.011","article-title":"Retraction notice to \u201cClinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial\u201d","volume":"53","author":"Kouchaki","year":"2025","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2026.106747_bib77","first-page":"568","article-title":"Statement of Retraction [retraction of: J Am Coll Nutr. 2017 Nov-Dec;36(8):660-665. doi: 10.1080\/07315724.2017.1347074.]","volume":"43","year":"2024","journal-title":"J Am Nutr Assoc"},{"issue":"3","key":"10.1016\/j.clnu.2026.106747_bib56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3168\/jdsc.2021-0183","article-title":"After the storm\u2014Perspectives on the taxonomy of lactobacillaceae","volume":"3","author":"Qiao","year":"2022","journal-title":"JDS Communications"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib57","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1099\/ijsem.0.004107","article-title":"A taxonomic note on the genus lactobacillus: description of 23 novel genera, emended description of the genus lactobacillus Beijerinck 1901, and union of lactobacillaceae and leuconostocaceae","volume":"70","author":"Zheng","year":"2020","journal-title":"Int J Syst Evol Microbiol"},{"issue":"7","key":"10.1016\/j.clnu.2026.106747_bib58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4014\/jmb.2206.06035","article-title":"The probiotic effects of the Saccharomyces cerevisiae 28-7 strain isolated from Nuruk in a DSS-induced colitis mouse model","volume":"32","author":"Lee","year":"2022","journal-title":"J Microbiol Biotechnol"},{"issue":"8","key":"10.1016\/j.clnu.2026.106747_bib59","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/AEM.02201-06","article-title":"Genotypic and physiological characterization of Saccharomyces boulardii , the probiotic strain of Saccharomyces cerevisiae","volume":"73","author":"Edwards-Ingram","year":"2007","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1078\/072320203770865873","article-title":"The taxonomic position of saccharomyces boulardii as evaluated by sequence analysis of the D1\/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial Cytochrome-c oxidase II gene","volume":"26","author":"Van Der Aa K\u00fchle","year":"2003","journal-title":"Syst Appl Microbiol"},{"issue":"11","key":"10.1016\/j.clnu.2026.106747_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14724","article-title":"Effect of probiotics supplementation on disease progression, depression, general health, and anthropometric measurements in relapsing-remitting multiple sclerosis patients: a systematic review and meta-analysis of clinical trials","volume":"75","author":"Mirashrafi","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clnu.2026.106747_bib62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.msard.2019.07.028","article-title":"Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis","volume":"35","author":"Rooney","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.clnu.2026.106747_bib63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/BRS.0b013e31815e3a10","article-title":"Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change","volume":"33","author":"Ostelo","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.clnu.2026.106747_bib65","first-page":"35","article-title":"Deconstructing the minimum clinically important difference (MCID)","volume":"14","author":"Molino","year":"2022","journal-title":"Orthop Res Rev"},{"issue":"3","key":"10.1016\/j.clnu.2026.106747_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.70577\/rxnrry04","article-title":"Biomarcadores inflamatorios simples y predicci\u00f3n de complicaciones en enfermedades cr\u00f3nicas","volume":"1","author":"Pin Franco","year":"2023","journal-title":"Salud Medicina e Innovaci\u00f3n Journal"},{"issue":"3","key":"10.1016\/j.clnu.2026.106747_bib67","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7705\/biomedica.6873","article-title":"Multiple sclerosis functional tests and their comparability with self-administered values: a pilot study. Pruebas funcionales en esclerosis m\u00faltiple y su comparabilidad con los valores de administraci\u00f3n aut\u00f3noma: estudio piloto","volume":"43","author":"Arenas-Vargas","year":"2023","journal-title":"Biomedica : revista del Instituto Nacional de Salud"},{"key":"10.1016\/j.clnu.2026.106747_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105743","article-title":"A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals","volume":"116","author":"Tr\u00e4ger","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clnu.2026.106747_bib69","article-title":"Multiple sclerosis in the Middle East and North Africa: perspectives and challenges","volume":"T21","author":"Costa","year":"2025","journal-title":"Int J MS Care"},{"issue":"4","key":"10.1016\/j.clnu.2026.106747_bib70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5603\/pjnns.103955","article-title":"Epidemiology of multiple sclerosis: global trends, regional differences, and clinical implications","volume":"59","author":"Kapica-Topczewska","year":"2025","journal-title":"Neurol Neurochir Pol"},{"issue":"14","key":"10.1016\/j.clnu.2026.106747_bib71","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Multiple Sclerosis J"},{"key":"10.1016\/j.clnu.2026.106747_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107963","article-title":"Exploring regional variations in probiotics: implications for efficacy and application","volume":"208","author":"Abavisani","year":"2025","journal-title":"Microb Pathog"},{"issue":"8","key":"10.1016\/j.clnu.2026.106747_bib73","article-title":"Geographical separation and ethnic origin influence the human gut microbial composition: a meta-analysis from a Malaysian perspective","volume":"7","author":"Dwiyanto","year":"2021","journal-title":"Microb Genom"},{"issue":"1","key":"10.1016\/j.clnu.2026.106747_bib75","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1038\/s41598-021-82311-3","article-title":"Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country","volume":"11","author":"Dwiyanto","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.clnu.2026.106747_bib74","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:40:56Z","timestamp":1789512056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":80,"alternative-id":["S0261561426001743"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106747","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical, mental and biochemical effects of probiotics in multiple sclerosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106747"}}